Skip to main content

Reconstitution of the Recombinant RanBP2 SUMO E3 Ligase Complex

  • Protocol
  • First Online:
SUMO

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1475))

Abstract

One of the few proteins that have SUMO E3 ligase activity is the 358 kDa nucleoporin RanBP2 (Nup358). While small fragments of RanBP2 can stimulate SUMOylation in vitro, the physiologically relevant E3 ligase is a stable multi-subunit complex comprised of RanBP2, SUMOylated RanGAP1, and Ubc9. Here, we provide a detailed protocol to in vitro reconstitute the RanBP2 SUMO E3 ligase complex. With the exception of RanBP2, reconstitution involves untagged full-length proteins. We describe the bacterial expression and purification of all complex components, namely an 86 kDa His-tagged RanBP2 fragment, the SUMO E2-conjugating enzyme Ubc9, RanGAP1, and SUMO1, and we provide a protocol for quantitative SUMOylation of RanGAP1. Finally, we present details for the assembly and final purification of the catalytically active RanBP2/RanGAP1*SUMO1/Ubc9 complex.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pichler A, Gast A, Seeler J-S et al (2002) The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108:109–120

    Article  CAS  PubMed  Google Scholar 

  2. Wu J, Matunis MJ, Kraemer D et al (1995) Nup358, a cytoplasmically exposed nucleoporin with peptide repeats, Ran-GTP binding sites, zinc fingers, a cyclophilin A homologous domain, and a leucine-rich region. J Biol Chem 270:14209–14213

    Article  CAS  PubMed  Google Scholar 

  3. Yokoyama N, Hayashi N, Seki T et al (1995) A giant nucleopore protein that binds Ran/TC4. Nature 376:184–188

    Article  CAS  PubMed  Google Scholar 

  4. Hamada M, Haeger A, Jeganathan KB et al (2011) Ran-dependent docking of importin-beta to RanBP2/Nup358 filaments is essential for protein import and cell viability. J Cell Biol 194:597–612

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Dawlaty MM, Malureanu L, Jeganathan KB et al (2008) Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. Cell 133:103–115

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Matunis MJ, Coutavas E, Blobel G (1996) A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J Cell Biol 135:1457–1470

    Article  CAS  PubMed  Google Scholar 

  7. Mahajan R, Delphin C, Guan T et al (1997) A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88:97–107

    Article  CAS  PubMed  Google Scholar 

  8. Zhu S, Goeres J, Sixt KM et al (2009) Protection from isopeptidase-mediated deconjugation regulates paralog-selective sumoylation of RanGAP1. Mol Cell 33:570–580

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Pichler A, Knipscheer P, Saitoh H et al (2004) The RanBP2 SUMO E3 ligase is neither HECT- nor RING-type. Nat Struct Mol Biol 11:984–991

    Article  CAS  PubMed  Google Scholar 

  10. Reverter D, Lima CD (2005) Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex. Nature 435:687–692

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Werner A, Flotho A, Melchior F (2012) The RanBP2/RanGAP1(∗)SUMO1/Ubc9 Complex Is a Multisubunit SUMO E3 Ligase. Mol Cell 46:287–298

    Article  CAS  PubMed  Google Scholar 

  12. Flotho A, Werner A, Winter T et al (2012) Recombinant reconstitution of sumoylation reactions in vitro. Methods Mol Biol 832:93–110

    Article  CAS  PubMed  Google Scholar 

  13. Sakin V, Richter SM, Hsiao H-H et al (2015) Sumoylation of the GTPase Ran by the RanBP2 SUMO E3 ligase complex. J Biol Chem 290:23589–23602

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Bernier-Villamor V, Sampson DA, Matunis MJ et al (2002) Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1. Cell 108:345–356

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We are very grateful to H. Ehret, A. Frank, and K. Meese for excellent technical assistance, and acknowledge funding from the Deutsche Forschungsgemeinschaft for research on the RanBP2 complex (SFB523 TPA18, DFG SFB638 TPB8 and GRK 1188). The authors would like to acknowledge networking support by the PROTEOSTASIS action BM1307, supported by COST (European Cooperation in Science and Technology).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Andreas Werner or Frauke Melchior .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this protocol

Cite this protocol

Ritterhoff, T. et al. (2016). Reconstitution of the Recombinant RanBP2 SUMO E3 Ligase Complex. In: Rodriguez, M. (eds) SUMO. Methods in Molecular Biology, vol 1475. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6358-4_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6358-4_3

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-6356-0

  • Online ISBN: 978-1-4939-6358-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics